A tale of two futures: HIV and antiretroviral therapy in San Francisco - PubMed (original) (raw)
Comment
A tale of two futures: HIV and antiretroviral therapy in San Francisco
S M Blower et al. Science. 2000.
Abstract
The effect of antiretroviral therapy (ART) in preventing human immunodeficiency virus (HIV) infections and averting acquired immunodeficiency syndrome (AIDS) deaths in the San Francisco gay community over the next 10 years was predicted. A transmission model was coupled with a statistical approach that enabled inclusion of a high degree of uncertainty in the potential treatment effects of ART (in terms of infectivity and survival), increase in risky behavior, and rate of emergence of drug resistance. Increasing the usage of ART in San Francisco would decrease the AIDS death rate and could substantially reduce the incidence rate.
Comment on
- Reversibility of HIV drug resistance.
Davenport MP. Davenport MP. Science. 2000 May 26;288(5470):1299. doi: 10.1126/science.288.5470.1299a. Science. 2000. PMID: 10847833 No abstract available.
Similar articles
- Reversibility of HIV drug resistance.
Davenport MP. Davenport MP. Science. 2000 May 26;288(5470):1299. doi: 10.1126/science.288.5470.1299a. Science. 2000. PMID: 10847833 No abstract available. - Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco.
Smith RJ, Okano JT, Kahn JS, Bodine EN, Blower S. Smith RJ, et al. Science. 2010 Feb 5;327(5966):697-701. doi: 10.1126/science.1180556. Epub 2010 Jan 14. Science. 2010. PMID: 20075214 - Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
Vittinghoff E, Scheer S, O'Malley P, Colfax G, Holmberg SD, Buchbinder SP. Vittinghoff E, et al. J Infect Dis. 1999 Mar;179(3):717-20. doi: 10.1086/314623. J Infect Dis. 1999. PMID: 9952385 - AIDS epidemic in San Francisco among men who report sex with men: successes and challenges of HIV prevention.
Katz MH. Katz MH. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14 Suppl 2:S38-46. doi: 10.1097/00042560-199700002-00008. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9070513 Review. - Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?
Velasco-Hernandez JX, Gershengorn HB, Blower SM. Velasco-Hernandez JX, et al. Lancet Infect Dis. 2002 Aug;2(8):487-93. doi: 10.1016/s1473-3099(02)00346-8. Lancet Infect Dis. 2002. PMID: 12150848 Review.
Cited by
- Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care.
Andrews JR, Wood R, Bekker LG, Middelkoop K, Walensky RP. Andrews JR, et al. J Infect Dis. 2012 Aug 15;206(4):543-51. doi: 10.1093/infdis/jis401. Epub 2012 Jun 18. J Infect Dis. 2012. PMID: 22711905 Free PMC article. - Frequency-dependent incidence in models of sexually transmitted diseases: portrayal of pair-based transmission and effects of illness on contact behaviour.
Lloyd-Smith JO, Getz WM, Westerhoff HV. Lloyd-Smith JO, et al. Proc Biol Sci. 2004 Mar 22;271(1539):625-34. doi: 10.1098/rspb.2003.2632. Proc Biol Sci. 2004. PMID: 15156921 Free PMC article. - What do mathematical models tell us about the emergence and spread of drug-resistant HIV?
Baggaley RF, Powers KA, Boily MC. Baggaley RF, et al. Curr Opin HIV AIDS. 2011 Mar;6(2):131-40. doi: 10.1097/COH.0b013e328343ad03. Curr Opin HIV AIDS. 2011. PMID: 21505388 Free PMC article. Review. - Antiviral agents and HIV prevention: controversies, conflicts, and consensus.
Cohen MS, Muessig KE, Smith MK, Powers KA, Kashuba AD. Cohen MS, et al. AIDS. 2012 Aug 24;26(13):1585-98. doi: 10.1097/QAD.0b013e3283543e83. AIDS. 2012. PMID: 22507927 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical